Regulatory & Legal

A new global study shows India leading in green energy commitment, while others lag. But the real challenge isn't just policy—it's a critical shortage of skills.

Following its transformative Porcupine acquisition, the miner posts huge profits and outlines a massive 2026 investment to double gold output.

With a major €12.5M EU funding package, Step Pharma is fast-tracking dencatistat, a novel therapy targeting a key vulnerability in ovarian and endometrial cancers.

With a pivotal data release on the horizon, Passage Bio heads to two major conferences. Can its dementia gene therapy program win over Wall Street?

A landmark partnership will deliver 70M gallons of sustainable aviation fuel, fueled by corporate demand for decarbonization and key government incentives.

Early data on YOLT-202 shows it can safely restore normal protein levels in patients with Alpha-1 Antitrypsin Deficiency, a major step toward a cure.

Serina Therapeutics enrolls the first patient in a trial for SER-252, a novel Parkinson's therapy designed to improve symptoms without current side effects.

Discover how a unique state tax system allows individuals and corporations to fund K-12 scholarships for thousands at no additional cost.

Amundi secures regulatory approval for an ICG board seat, paving the way for a 9.9% stake and signaling a major strategic push into alternative assets.

A class action lawsuit reveals a massive pump-and-dump scheme targeting China Liberal Education, raising questions of corporate complicity and investor recourse.

As VerticalScope preps its 2025 results, investors watch if its pivot to AI and e-commerce can overcome ad market and search engine challenges.

Abony Acquisition Corp. I prices its $200M IPO, testing a maturing SPAC market with a veteran team targeting high-growth tech and defense firms.

With major investor conferences ahead, Ceribell showcases impressive revenue growth fueled by its AI-driven EEG system and a string of new FDA clearances.

After a major pipeline pivot, Keros Therapeutics faces investors with a new lead drug, a fortified balance sheet, and a high-stakes strategy to prove.

The Dubai-based SPAC is separating its shares and warrants. Here's what this key move means for investors and the company's search for a merger target.

Lexington-based insurer Mountain Life promises agents unmatched personal service. But can this high-touch model survive a new owner's ambitious growth plans?

Wyndham Hotels & Resorts reports record development but takes a major Q4 loss from a franchisee's insolvency, yet signals confidence with a dividend hike.

Compass Diversified sets its earnings date, putting its post-Lugano strategy and portfolio health under intense scrutiny from investors.

A $3.5T financial giant partners with a Trump-linked DeFi firm to integrate stablecoins and tokenize real estate, bridging the gap between TradFi and crypto.

A new AI tool aims to slash errors in critical Medicare documents, promising huge savings for health plans and clearer information for millions of members.